Depression and anxiety are associated with high health care utilization and mortality among adults with congenital heart disease.


Journal

International journal of cardiology
ISSN: 1874-1754
Titre abrégé: Int J Cardiol
Pays: Netherlands
ID NLM: 8200291

Informations de publication

Date de publication:
01 Feb 2019
Historique:
received: 20 06 2018
revised: 31 07 2018
accepted: 03 09 2018
pubmed: 19 9 2018
medline: 28 8 2019
entrez: 19 9 2018
Statut: ppublish

Résumé

The significance of depression/anxiety among ACHD patients in terms of health care utilization is unknown and data on the association with mortality are scarce. Analyses comprised 8334 ACHD patients, age ≥ 18 years, insured by a large healthcare organization (2007-2011). Depression/anxiety were determined by diagnoses and treatments recorded in the organization database. Adjusted utilization relative rates (RRs) were estimated with negative binomial models and mortality hazard ratios (HRs) with the Cox proportional hazard model. ACHD patients with depression/anxiety (N = 2950, 35%) were more likely to be older (mean ± SD: 54 ± 17 vs. 45 ± 18 years), women (61% vs. 45%), and have comorbidities than counterparts without depression/anxiety. Following multivariable adjustment, patients with depression/anxiety had more primary care and cardiology clinic visits, more emergency department visits and more hospitalizations. RRs (95% confidence interval) were: 1.31 (1.27-1.35); 1.07 (1.01-1.13); 1.60 (1.46-1.77); and 1.18 (1.08-1.29) respectively, for diagnosis before the study period, and 1.36 (1.31-1.42); 1.22 (1.14-1.30); 1.43 (1.24-1.60) and 1.47 (1.33-1.64), respectively, for diagnosis during the study. Stratifying by age, the highest adjusted primary care and cardiology visit RRs were found among 18-24 years old patients and the lowest among patients ≥65 years. Between 2007 and 2017, 905 patients died. Depression/anxiety were associated with increased mortality risk with adjusted HRs: 1.10 (95% CI: 0.94-1.29) for past diagnosis and 1.40 (1.17-1.67) for study period depression/anxiety diagnosis. Depression/anxiety in ACHD patients is associated with increased health-care utilization and a higher risk of death. The efficacy of addressing patients' psychosocial needs in optimizing health-care utilization and improving prognosis needs further evaluation.

Sections du résumé

BACKGROUND BACKGROUND
The significance of depression/anxiety among ACHD patients in terms of health care utilization is unknown and data on the association with mortality are scarce.
METHODS METHODS
Analyses comprised 8334 ACHD patients, age ≥ 18 years, insured by a large healthcare organization (2007-2011). Depression/anxiety were determined by diagnoses and treatments recorded in the organization database. Adjusted utilization relative rates (RRs) were estimated with negative binomial models and mortality hazard ratios (HRs) with the Cox proportional hazard model.
RESULTS RESULTS
ACHD patients with depression/anxiety (N = 2950, 35%) were more likely to be older (mean ± SD: 54 ± 17 vs. 45 ± 18 years), women (61% vs. 45%), and have comorbidities than counterparts without depression/anxiety. Following multivariable adjustment, patients with depression/anxiety had more primary care and cardiology clinic visits, more emergency department visits and more hospitalizations. RRs (95% confidence interval) were: 1.31 (1.27-1.35); 1.07 (1.01-1.13); 1.60 (1.46-1.77); and 1.18 (1.08-1.29) respectively, for diagnosis before the study period, and 1.36 (1.31-1.42); 1.22 (1.14-1.30); 1.43 (1.24-1.60) and 1.47 (1.33-1.64), respectively, for diagnosis during the study. Stratifying by age, the highest adjusted primary care and cardiology visit RRs were found among 18-24 years old patients and the lowest among patients ≥65 years. Between 2007 and 2017, 905 patients died. Depression/anxiety were associated with increased mortality risk with adjusted HRs: 1.10 (95% CI: 0.94-1.29) for past diagnosis and 1.40 (1.17-1.67) for study period depression/anxiety diagnosis.
CONCLUSIONS CONCLUSIONS
Depression/anxiety in ACHD patients is associated with increased health-care utilization and a higher risk of death. The efficacy of addressing patients' psychosocial needs in optimizing health-care utilization and improving prognosis needs further evaluation.

Identifiants

pubmed: 30224258
pii: S0167-5273(18)33988-3
doi: 10.1016/j.ijcard.2018.09.005
pii:
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

81-86

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2018 Elsevier B.V. All rights reserved.

Auteurs

Michal Benderly (M)

Cardiovascular Epidemiology Unit, Gertner Institute for Epidemiology and Health Policy Research, Sheba Medical Center, Ramat-Gan, Israel; Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel. Electronic address: bender@post.tau.ac.il.

Ofra Kalter-Leibovici (O)

Cardiovascular Epidemiology Unit, Gertner Institute for Epidemiology and Health Policy Research, Sheba Medical Center, Ramat-Gan, Israel; Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Dahlia Weitzman (D)

Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel; Morris Kahn & Maccabi Institute for Research and Innovation, Maccabi Healthcare Services, Israel.

Leonard Blieden (L)

Adult Congenital Heart Disease Unit, Rabin Medical Center, Sorasky Faculty of Medicine, Tel Aviv University, Petach Tikva, Israel.

Jonathan Buber (J)

Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel; Leviev Heart Center, Sheba Medical Center, Ramat-Gan, Israel.

Alexander Dadashev (A)

Adult Congenital Heart Disease Unit, Rabin Medical Center, Sorasky Faculty of Medicine, Tel Aviv University, Petach Tikva, Israel.

Efrat Mazor-Dray (E)

Ben-Gurion University of the Negev, Negev, Israel.

Avraham Lorber (A)

Pediatric Cardiology and GUCH Unit, Rambam Health Care Campus, Technion Faculty of Medicine, Haifa, Israel.

Amiram Nir (A)

Department of Pediatric Cardiology, Hadassah, Hebrew University Medical Center, Jerusalem, Israel.

Sergei Yalonetsky (S)

Pediatric Cardiology and GUCH Unit, Rambam Health Care Campus, Technion Faculty of Medicine, Haifa, Israel.

Yaron Razon (Y)

Ben-Gurion University of the Negev, Negev, Israel; Pediatric cardiology service, Pediatric Department, Assuta Ashdod University Hospital, Ashdod, Israel.

Gabriel Chodick (G)

Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel; Morris Kahn & Maccabi Institute for Research and Innovation, Maccabi Healthcare Services, Israel.

Rafael Hirsch (R)

Adult Congenital Heart Disease Unit, Rabin Medical Center, Sorasky Faculty of Medicine, Tel Aviv University, Petach Tikva, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH